47
1
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T61490 | P2X receptor-1 | ||
P2X receptor-1 is a potential inhibitor of P2X receptor for the treatment of pain and inflammation. | |||
T10466 | BAY-1797 | P2X Receptor | |
BAY-1797 is an orally active and selective P2X4 antagonist (IC50: 211 nM against human P2X4) with anti-nociceptive and anti-inflammatory effects. BAY-1797 displays no or very weak activity on the other P2X ion channels. | |||
T22518 | 5-BDBD | P2X Receptor | |
5-BDBD is a potent and selective P2X4 receptor antagonist. 5-BDBD inhibits rP2X4R-mediated currents with an IC50 of 0.75 μM. 5-BDBD completely blocked the basal and acute hyperalgesia induced by NTG. | |||
T10207 | A 438079 | P2X Receptor | |
A 438079 is a potent, and selective antagonist of P2X7 receptor (pIC50: 6.9). | |||
T3690 | A-740003 | A 740003 | P2X Receptor |
A-740003 (A 740003) is an effective and specific P2X7 receptor antagonist (IC50: 18/40 nM, for rat/human). It can reduce nociception in animal models of persistent neuropathic and inflammatory pain, and also reduce neuro... | |||
T3639 | A-804598 | A 804598 | P2X Receptor |
A-804598 is a competitive and selective P2X7 receptor antagonist (IC50: 10 nM, rat; 9 nM, mouse; 11 nM, human). | |||
T5513 | RO-3 | P2X Receptor | |
RO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor | |||
T14385 | AZD9056 hydrochloride | P2X Receptor | |
AZD9056 hydrochloride is a P2X7 inhibitor,Which plays a significant role in pain-causing diseases and inflammation. | |||
T8946 | Indophagolin | P2X Receptor , 5-HT Receptor , Autophagy | |
Indophagolin is a potent, indoline-containing autophagy inhibitor with IC50 of 140 nM. Indophagolin antagonizes the purinergic receptor P2X4 as well as P2X1 and P2X3 with IC50s of 2.71, 2.40 and 3.49 μM, respectively. | |||
T9519 | Eliapixant | BAY 1817080 | P2X Receptor |
Eliapixant (BAY 1817080) (BAY 1817080) is a potent and selective P2X3 receptor antagonist, with an IC50 of 8 nM. Eliapixant can be used for the research of refractory chronic cough. | |||
T2087 | AF-353 | Ro-4 | P2X Receptor |
AF-353 (Ro-4), an effective and orally bioavailable antagonist of the P2X3/P2X2/3 receptor, inhibits human and rat P2X3 (pIC50= 8.0). | |||
T8333 | Aurintricarboxylic acid | ATA,NSC-4056,NSC4056,NSC 4056 | Apoptosis , P2X Receptor , Influenza Virus , Topoisomerase |
Aurintricarboxylic acid (NSC-4056) is a strong inhibitor of topoisomerases and other nucleases. It is a potent inhibitor of ribonuclease and topoisomerase II by preventing the binding of the nucleic acid to the enzyme. | |||
T40045 | Sivopixant | S-600918,Sivopixant | P2X Receptor |
Sivopixant (S-600918) (S-600918) is a potent and selective antagonist of P2X3 receptor (P2X3 IC 50 =4.2 nM; P2X2/3 IC 50 =1100 nM). Sivopixant shows strong analgesic effect . | |||
TQ0002 | A-317491 | ABT 202 | P2X Receptor |
A-317491 (ABT 202) is a non-nucleotide P2X3 ( Ki: 22 nM) and P2X2/3 receptor (Ki: 9 nM) antagonist, which inhibits calcium flux mediated by the receptors. | |||
T14366 | AZ10606120 dihydrochloride | P2X Receptor | |
AZ10606120 dihydrochloride is a selectable, potent, high-affinity receptor antagonist with K D values of 1.4 and 19 nM at human and rat P2X 7 receptors, respectively. AZ10606120 dihydrochloride inhibits tumor growth and ... | |||
T4298 | JNJ-47965567 | JNJ-479655 | P2X Receptor |
JNJ-47965567 (JNJ-479655) is a selective antagonist of the purinergic receptor P2X subtype 7 (P2X7), a ligand-gated ion channel(with pKis of 7.9 and 8.7 for human and rat P2X7, respectively). | |||
T12568 | PSB-12062 | N-(p-Methylphenylsulfonyl)phenoxazine | P2X Receptor |
PSB-12062 (N-(p-Methylphenylsulfonyl)phenoxazine) is a potent and selective antagonist of P2X4(IC50 of 1.38 μM for human P2X4). | |||
T14920 | CE-224535 | PF-04905428 | P2X Receptor |
CE-224535 (PF-04905428) is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies. | |||
T2694 | KN-62 | CaMK , P2X Receptor , Autophagy | |
KN-62 is a potent and specific Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor with Ki of 0.9 μM. | |||
T9786 | Lu AF27139 | P2X Receptor | |
Lu AF27139 is an effective and selective antagonist of P2X7 receptor (IC50s of 12 and 2.4 nM for human and rat, Kis of 22, 54, and 13 nM for mouse, human, and rat, respectively). Lu AF27139 can be used in CNS diseases st... | |||
T9833 | Opiranserin hydrochloride | P2X Receptor , GlyT , 5-HT Receptor | |
Opiranserin (VVZ-149) hydrochloride is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. It shows antagonistic activity on rP2X3 (IC50... | |||
T14844 | BX430 | P2X Receptor , Calcium Channel | |
BX430 is used for chronic pain and cardiovascular disease and it is a potent and selective noncompetitive allosteric human P2X4 receptor channels antagonist with an IC50 of 0.54 μM. BX430 has species specificity. | |||
T7805 | GW791343 dihydrochloride | GW791343 (HCl) | P2X Receptor |
GW791343 dihydrochloride (GW791343 (HCl)) is a P2X7 allosteric modulator. | |||
T2673 | A 438079 hydrochloride | A 438079 (hydrochloride),A-438079 hydrochloride,A-438079 HCl | P2X Receptor |
A 438079 hydrochloride (A-438079 HCl) is a potent and selective P2X7 receptor antagonist with pIC50 of 6.9. | |||
T5099 | Gefapixant | RO 4926219,AF219,MK-7264 | P2X Receptor |
Gefapixant (AF219) is a P2X3 receptor (P2X3R) antagonist with IC50 of ~30 nM at recombinant hP2X3 homotrimers and 100-250 nM at hP2X2/3 heterotrimeric receptors. | |||
T16399 | Opiranserin | P2X Receptor , GlyT , 5-HT Receptor | |
Opiranserin is a development as an injectable agent for the treatment of postoperative pain. Opiranserin is a non-opioid and non-NSAID analgesic candidate and is a dual antagonist of glycine transporter type 2 (GlyT2) an... | |||
T6526 | GW791343 trihydrochloride | GW791343 3HCl | P2X Receptor |
GW791343 trihydrochloride (GW791343 3HCl) is aHCl salt form of GW791343, which is a non-competitive allosteric modulator of human P2X7 receptor inhibitor with pIC50 of 7. | |||
T61566 | P2X7 receptor antagonist-2 | ||
P2X7 receptor antagonist-2 is a highly potent antagonist of the P2X7 receptor, exhibiting a pIC50 value range of 6.5-7.5. Its efficacy in combating neuroinflammation has been demonstrated [1]. | |||
T75162 | P2X2/3 modulator-1 | ||
P2X2/3 Modulator-1 (Compound 46) serves as a modulator of P2X2/3 receptors and has applications in researching pain, central nervous system disorders, and inflammation [1]. | |||
T75254 | P2X7-IN-2 TFA | ||
P2X7-IN-2 TFA (compound 58) is a P2X7 receptor inhibitor that demonstrates the capability to inhibit IL-Iβ release effectively with an IC50 value of 0.01 nM. It is utilized in research focused on autoimmunity, inflammati... | |||
T72198 | P2X7 receptor antagonist-3 | ||
P2X7 receptor antagonist-3 is a powerful inhibitor of the P2X7 receptor, exhibiting IC50 values of 4.2 nM in humans and 6.8 nM in rats, indicating its high potency in both species. | |||
T62488 | P2X7 receptor antagonist-1 | ||
P2X7 receptor antagonist-1 is a purinergic P2X7 receptor antagonist with anti-neuroinflammatory effects. | |||
T79115 | P2X3 antagonist 38 | P2X Receptor | |
Compound 38, also known as Compound 4, is a potent, orally active P2X3 antagonist that demonstrates inhibitory activity with IC50 values of 0.132 µM, 0.165 µM, and 0.421 µM against human (hP2X3), rat (rP2X3), and guinea ... | |||
T63197 | P2X3 antagonist 36 | ||
P2X3 antagonist 36 is a P2X3 antagonist. | |||
T73335 | P2X7-IN-2 | ||
P2X7-IN-2, a P2X7 receptor inhibitor, effectively suppresses IL-Iβ release, demonstrating an inhibitory concentration (IC50) value of 0.01 nM. This compound is utilized in the study of autoimmunity, inflammation, and car... | |||
T78606 | P2X3-IN-1 | P2X Receptor | |
P2X3-IN-1 (example 7) is a P2X3 receptor inhibitor suitable for research on neurogenic diseases [1]. | |||
T10560 | P2X3 antagonist 34 | BLU-5937 | |
P2X3 antagonist 34, a potent, selective, and orally active antagonist, targets the P2X3 homotrimeric receptor, exhibiting IC50s of 25 nM, 92 nM, and 126 nM for human, rat, and guinea pig P2X3 receptors respectively. It s... | |||
T81579 | P2X7 receptor antagonist-4 | ||
Compound 14a (P2X7 receptor antagonist-4) is a P2X7R antagonist with IC50 values of 64.7 nM in humans and 10.1 nM in mice. It inhibits the activation of the NLRP3 inflammasome, which subsequently reduces the expression o... | |||
T8635 | CI 75300 | P2X Receptor | |
CI 75300 targets the P2X purinoceptor 7 (human). | |||
T16564 | PPADS tetrasodium | P2X Receptor , Na+/Ca2+ Exchanger | |
PPADS tetrasodiuma is a potent P2X receptor antagonist and inhibitor of the inverse mode of Na/Ca²⁺ exchange in guinea pig airway smooth muscle and is neuroprotective against glutamate/NMDA toxicity.PPADS tetrasodiuma in... | |||
T69255 | MRS-2339 | ||
MRS-2339 is a P2X receptor activator. | |||
T33506 | MRS2220 | MRS 2220,MRS-2220 | |
MRS2220 is a selective enhancer of the ATP effects at fast desensitizing P2X (P2X1 and P2X3) receptors. | |||
TP2297 | TNP-ATP triethylammonium salt | Others | |
P2X receptor antagonist | |||
T69053 | ANAPP3 | ||
ANAPP3 is a P2x-purinoceptor antagonist. It affects contractions in various muscle groups and tissues. | |||
T71950 | PSB-12054 | ||
PSB-12054 is a potent P2X4 receptor inhibitor. PSB-12054 has IC(50) of 0.189 μM and good selectivity versus the other human P2X receptor subtypes. | |||
T39891 | 8-Bromo-ATP | 8-Bromoadenosine 5'-triphosphate,8-Bromo-ATP,8-Br-ATP | |
8-Bromo-ATP (8-Bromoadenosine 5'-triphosphate) is a purinergic P2X receptor agonist and an ATP analogue. It exhibits cytotoxicity towards multiple myeloma cells, with an IC50 of 23.1 μM. | |||
T71651 | GSK1370319A | ||
GSK1370319A is a potent P2X7 antagonist (IC50 = 3.2 nM). GSK1370319A inhibits ATP-induced increase in IL-1β release and caspase 1 activation in lipopolysaccharide (LPS)-primed mixed glia by blocking assembly of the infla... |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T4S0536 | Bullatine A | Apoptosis , P2X Receptor | |
1. Bullatine A, a diterpenoid alkaloid of the genus Aconitum, possesses anti-rheumatic, anti-inflammatory and anti-nociceptive effects, may be used for the treatment of neurodegenerative diseases such as arthritis. |